Based on our expertise gained in cardiovascular disease, we have now developed two new research programmes, the first in neuroprotection specific to ischemic stroke and the second in cancer, investigating how best to reduce the damage to the heart from chemotherapy. 

Within our framework, as part of UCL’s Institute of Cardiovascular Science, we undertake basic and clinical research at the highest level, train clinical and basic scientist and continue to strive to improve the treatment options available to patients.